Pharma News

Keep updating your pharma knowledge
28 Dec 2014

Indian Biosimilar market valuation

Indian biosimilar market is around 2000 Crores.

Percentage of Biosimilar market over total pharma market


Who are the leading players in Indian biosimilar market?

  • Biocon – Streptokinase, EPO Filgrastim, MAbs
  • Zydus – Insulin, Streptokinase, Filgrastim
  • DRL – Rituximab, Filgrastim, Darbepoetin alfa
  • Lupin – EGFR, Abciximab
  • Ranbaxy – EPO Filgrastim, Interferon, Infliximab
  • Wockhardt – Insulin, EPO, Insulin Glargine





1 Response

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!